GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast A/S (OCSE:COLO B) » Definitions » PEG Ratio

Coloplast A/S (OCSE:COLO B) PEG Ratio : 5.40 (As of May. 10, 2024)


View and export this data going back to 1993. Start your Free Trial

What is Coloplast A/S PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Coloplast A/S's PE Ratio without NRI is 37.27. Coloplast A/S's 5-Year EBITDA growth rate is 6.90%. Therefore, Coloplast A/S's PEG Ratio for today is 5.40.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for Coloplast A/S's PEG Ratio or its related term are showing as below:

OCSE:COLO B' s PEG Ratio Range Over the Past 10 Years
Min: 0.77   Med: 3.25   Max: 68.81
Current: 5.4


During the past 13 years, Coloplast A/S's highest PEG Ratio was 68.81. The lowest was 0.77. And the median was 3.25.


OCSE:COLO B's PEG Ratio is ranked worse than
81.97% of 244 companies
in the Medical Devices & Instruments industry
Industry Median: 1.99 vs OCSE:COLO B: 5.40

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


Coloplast A/S PEG Ratio Historical Data

The historical data trend for Coloplast A/S's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast A/S PEG Ratio Chart

Coloplast A/S Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.37 2.05 5.48 5.40 4.88

Coloplast A/S Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.89 5.50 4.88 5.03 6.14

Competitive Comparison of Coloplast A/S's PEG Ratio

For the Medical Instruments & Supplies subindustry, Coloplast A/S's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coloplast A/S's PEG Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast A/S's PEG Ratio distribution charts can be found below:

* The bar in red indicates where Coloplast A/S's PEG Ratio falls into.



Coloplast A/S PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

Coloplast A/S's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=37.266313932981/6.90
=5.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


Coloplast A/S  (OCSE:COLO B) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


Coloplast A/S PEG Ratio Related Terms

Thank you for viewing the detailed overview of Coloplast A/S's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Coloplast A/S (OCSE:COLO B) Business Description

Traded in Other Exchanges
Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast A/S (OCSE:COLO B) Headlines

No Headlines